August 08, 2024 Customer Newsletter
-
Cardioprotective Potential of GLP-1 Therapies
-
ABIM Certification Exam - Its Time!
-
Patients Forsake Care Amid Insurance Barriers
-
Remote Doctor Appointments Remain Popular
A Deeper Understanding of GLP-1 Mechanism of Action Will Open Doors for Future Uses
American Society of Preventive Cardiology says GLP-1 therapies are proactive against both cardiology and kidney diseases, though the mechanisms need to be studied.
A Deeper Understanding of GLP-1 Mechanism of Action Will Open Doors for Future Uses
AHA: Semaglutide Significantly Reduces MACE in Adults With Overweight or Obesity, CVD
Study for the ABIM Certification Exam Now!
Still haven't made a study plan for the upcoming ABIM certification exam yet? No worries. Med-Challenger has the tools you need to help you optimize your exam score.
IM Physicians love our review course because it offers:
- Internal Medicine exam review questions that follow the ABIM Blueprint
- CME credits earned while studying with board-style questions
- A Board Exam Simulator for realistic practice
- Detailed explanations to understand why answers are correct or incorrect
- Colorful images for visual learning
- An easy-to-read dashboard for seamless navigation
Try the ABIM Internal Medicine Exam Review for free today! Follow us and send us a message on Facebook to get 10%.
Exhausted By Prior Authorization, Many Patients Abandon Care: AMA SurveyNot surprisingly, when private or public insurers put up barriers to patients getting the care they need, the patients will abandon the effort. This usually results with the patient coming back in worse shape (19%), damaged permanently (7%), or suffering an adverse event (13%). That results in a higher toll on both the patients and the healthcare system. Exhausted By Prior Authorization, Many Patients Abandon Care: AMA SurveyRemote Doctor Appointments Remain PopularWell, would you rather discuss the test results over the phone with a doctor or spend two hours going through the whole 'see the doctor at the office' routine? State licensing and reimbursement still limit telehealth options, while regulations fail to address some of the absurdities of prescribing by email without ever seeing the patient. |